Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001347178-21-000005
Filing Date
2021-02-11
Accepted
2021-02-11 07:04:13
Documents
110
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K vnda-20201231.htm   iXBRL 10-K 2458347
2 EX-10.40 vndaex104012312020.htm EX-10.40 28386
3 EX-10.41 vndaex104112312020.htm EX-10.41 28741
4 EX-21.1 vnda12312020ex211.htm EX-21.1 6331
5 EX-23.1 vnda12312020ex231.htm EX-23.1 2374
6 EX-31.1 vnda12312020ex311.htm EX-31.1 10706
7 EX-31.2 vnda12312020ex312.htm EX-31.2 10592
8 EX-32.1 vnda12312020ex321.htm EX-32.1 6691
14 vnda-20201231_g1.gif GRAPHIC 4652
15 vnda-20201231_g2.jpg GRAPHIC 21579
16 vnda-20201231_g3.gif GRAPHIC 3959
17 vnda-20201231_g4.jpg GRAPHIC 270494
18 vnda-20201231_g5.jpg GRAPHIC 189764
  Complete submission text file 0001347178-21-000005.txt   10864966

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vnda-20201231.xsd EX-101.SCH 67080
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vnda-20201231_cal.xml EX-101.CAL 122812
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vnda-20201231_def.xml EX-101.DEF 272969
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vnda-20201231_lab.xml EX-101.LAB 746300
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vnda-20201231_pre.xml EX-101.PRE 501289
19 EXTRACTED XBRL INSTANCE DOCUMENT vnda-20201231_htm.xml XML 1672878
Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Filer) CIK: 0001347178 (see all company filings)

EIN.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34186 | Film No.: 21616644
SIC: 2834 Pharmaceutical Preparations